It's official—AbbVie dumps Rova-T after another lung cancer fail - FierceBiotech
It's official—AbbVie dumps Rova-T after another lung cancer fail FierceBiotech
Lung cancer patients taking Rova-T as a frontline treatment didn't outlive those on placebo, prompting a committee to recommend AbbVie halt the study.
Comments
Post a Comment